Genetic polymorphism of CYP2D6 in Korean population.

被引:0
作者
Jung, HJ
Kim, MK
Yoon, YR
Park, JY
Shin, JG
机构
[1] Inje Univ, Coll Med, Dept Pharmacol, Pusan, South Korea
[2] Pusan Paik Hosp, Clin Pharmacol Ctr, Pusan, South Korea
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P38 / P38
页数:1
相关论文
共 50 条
[41]   Genetic polymorphism of CYP2D6 in systemic lupus erythematosus patients [J].
Baranska, Malgorzata ;
Rychlik-Sych, Mariola ;
Kaczorowska, Anna ;
Skretkowicz, Jadwiga .
PHARMACOLOGICAL REPORTS, 2007, 59 :62-62
[42]   EFFECTS OF CYP2D6 GENETIC POLYMORPHISM ON THE PHARMACOKINETICS OF TOLPERISONE IN KOREANS [J].
Byeon, J. ;
Lee, H. ;
Choi, C. ;
Jang, C. ;
Bae, J. ;
Lee, S. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 :S24-S24
[43]   Impact of CYP2D6 Genetic Polymorphism on Tramadol Pharmacokinetics and Pharmacodynamics [J].
Siew Hua Gan ;
Rush Ismail ;
Wan Aasim Wan Adnan ;
Wan Zulmi .
Molecular Diagnosis & Therapy, 2007, 11 (3) :171-181
[44]   Significance of the genetic polymorphism of CYP2D6 in patients with bullous pemphigoid [J].
Rychlik-Sych, Mariola ;
Baranska, Malgorzata ;
Wojtczak, Anna ;
Skretkowicz, Jadwiga ;
Zebrowska, Agnieszka ;
Waszczykowska, Elzbieta .
PHARMACOLOGICAL REPORTS, 2015, 67 :37-38
[45]   Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro [J].
Hu, Xiao-xia ;
Yuan, Ling-jing ;
Fang, Ping ;
Mao, Yong-Hui ;
Zhan, Yun-yun ;
Li, Xiang-yu ;
Dai, Da-peng ;
Cai, Jian-ping ;
Hu, Guo-xin .
DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (02) :133-138
[46]   Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics [J].
Gan, Siew Hua ;
Ismail, Rusli ;
Adnan, Wan Aasim Wan ;
Zulmi, Wan .
MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (03) :171-181
[47]   Usefulness of hepatocytes for evaluating the genetic polymorphism of CYP2D6 substrates [J].
Komura, H ;
Iwaki, M .
XENOBIOTICA, 2005, 35 (06) :575-587
[48]   CYP2D6 genetic polymorphism and psychiatry patients' hospitalization period [J].
Penas-LLedo, Eva M. ;
LLerena, Adrian .
BIOMARKERS IN MEDICINE, 2013, 7 (06) :915-916
[49]   Genetic polymorphism of CYP2D6 and lung cancer risk. [J].
Arnaud, L ;
Gallegos, MP ;
Gomez, BC ;
Morgan, G ;
Flores, MC ;
Rangel, H ;
Zuiga, GM .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) :270-270
[50]   CYP2D6 genetic polymorphism and extrapyramidal effects of antipsychotic drugs [J].
Plesnicar, BK ;
Dolzan, V ;
Zalar, B ;
Tomori, M ;
Breskvar, K .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 :S266-S266